Literature DB >> 10069005

Colicins--exocellular lethal proteins of Escherichia coli.

J Smarda1, D Smajs.   

Abstract

Colicins are toxic exoproteins produced by bacteria of colicinogenic strains of Escherichia coli and some related species of Enterobacteriaceae, during the growth of their cultures. They inhibit sensitive bacteria of the same family. About 35% E. coli strains appearing in human intestinal tract are colicinogenic. Synthesis of colicins is coded by genes located on Col plasmids. Until now more than 34 types of colicins have been described, 21 of them in greater detail, viz. colicins A, B, D, E1-E9, Ia, Ib, JS, K, M, N, U, 5, 10. In general, their interaction with sensitive bacteria includes three steps: (1) binding of the colicin molecule to a specific receptor in the bacterial outer membrane; (2) its translocation through the cell envelope; and (3) its lethal interaction with the specific molecular target in the cell. The classification of colicins is based on differences in the molecular events of these three steps.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10069005     DOI: 10.1007/bf02816372

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  132 in total

Review 1.  THE BACTERIOCINS.

Authors:  P REEVES
Journal:  Bacteriol Rev       Date:  1965-03

2.  Cloning and characterization of the ColE7 plasmid.

Authors:  K F Chak; W S Kuo; F M Lu; R James
Journal:  J Gen Microbiol       Date:  1991-01

3.  Localization of the site of cleavage of ribosomal RNA by colicin E3. Placement on the small ribosomal subunit by electron microscopy of antibody--complementary oligodeoxynucleotide complexes.

Authors:  L S Lasater; P A Cann; D G Glitz
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

4.  Anaerobic control of colicin E1 production.

Authors:  J M Eraso; G M Weinstock
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

5.  The cytoplasmic membrane as a site of the primary effect of colicins on eukaryotic cells.

Authors:  V Viklický; J Smarda; P Dráber; Z Pokorná; J Mach; P Dráber
Journal:  Folia Biol (Praha)       Date:  1979       Impact factor: 0.906

6.  Interaction of colicins with bacterial cells. 3. Colicin-tolerant mutations in Escherichia coli.

Authors:  M Nomura; C Witten
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

7.  Nucleotide sequencing of the structural gene for colicin N reveals homology between the catalytic, C-terminal domains of colicins A and N.

Authors:  A P Pugsley
Journal:  Mol Microbiol       Date:  1987-11       Impact factor: 3.501

8.  Evidence that the immunity protein inactivates colicin 5 immediately prior to the formation of the transmembrane channel.

Authors:  H Pilsl; V Braun
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

9.  Transport of vitamin B12 in Escherichia coli: common receptor sites for vitamin B12 and the E colicins on the outer membrane of the cell envelope.

Authors:  D R Di Masi; J C White; C A Schnaitman; C Bradbeer
Journal:  J Bacteriol       Date:  1973-08       Impact factor: 3.490

10.  Escherichia coli K317, formerly used to define colicin group E2, produces colicin E7, is immune to colicin E2, and carries a bacteriophage-restricting conjugative plasmid.

Authors:  B M Males; B A Stocker
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

View more
  29 in total

1.  Binding domains of colicins E1, E2 and E3 in the receptor protein BtuB of Escherichia coli.

Authors:  J Smarda; L Macholán
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Translocation of colicin from the receptor to the inner cell membrane: function of the peptidoglycan layer.

Authors:  J Smarda; P Matĕjková; A Vavrícková
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

3.  A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria.

Authors:  Rachel D Hood; Pragya Singh; Fosheng Hsu; Tüzün Güvener; Mike A Carl; Rex R S Trinidad; Julie M Silverman; Brooks B Ohlson; Kevin G Hicks; Rachael L Plemel; Mo Li; Sandra Schwarz; Wenzhuo Y Wang; Alexey J Merz; David R Goodlett; Joseph D Mougous
Journal:  Cell Host Microbe       Date:  2010-01-21       Impact factor: 21.023

4.  Smarter arrow now available in the food safety quiver.

Authors:  Todd R Callaway; Trisha G Sheridan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-23       Impact factor: 11.205

5.  Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Authors:  Matija Rijavec; Maruska Budic; Peter Mrak; Manica Müller-Premru; Zdravko Podlesek; Darja Zgur-Bertok
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

6.  The role of SOS boxes in enteric bacteriocin regulation.

Authors:  Osnat Gillor; Jan A C Vriezen; Margaret A Riley
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

7.  Novel colicin Fy of Yersinia frederiksenii inhibits pathogenic Yersinia strains via YiuR-mediated reception, TonB import, and cell membrane pore formation.

Authors:  Juraj Bosák; Petra Laiblová; Jan Smarda; Daniela Dedicová; David Smajs
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

Review 8.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

9.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

Review 10.  Gassericin A: a circular bacteriocin produced by lactic acid bacteria Lactobacillus gasseri.

Authors:  Neha Pandey; R K Malik; J K Kaushik; Garima Singroha
Journal:  World J Microbiol Biotechnol       Date:  2013-05-28       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.